8 news items
Precision BioSciences Reports First Quarter 2024 Financial Results and Provides Business Update
CRBU
DTIL
TGTX
13 May 24
with chronic hepatitis B. Currently, it is estimated that approximately 300 million people worldwide are afflicted with chronic Hepatitis B. PBGENE-HBV
TG Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
TGTX
1 May 24
(RMS) is a chronic demyelinating disease of the central nervous system (CNS) and includes people with relapsing-remitting multiple sclerosis (RRMS
TG Therapeutics Announces Additional Data Presentations for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting
TGTX
18 Apr 24
multiple sclerosis (RMS) is a chronic demyelinating disease of the central nervous system (CNS) and includes people with relapsing-remitting multiple
TG Therapeutics Announces Presentation of Data for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting
TGTX
15 Apr 24
sclerosis (RMS) is a chronic demyelinating disease of the central nervous system (CNS) and includes people with relapsing-remitting multiple sclerosis
Precision BioSciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business Update
CRBU
DTIL
TGTX
27 Mar 24
PBGENE-HBV (Viral Elimination Program): Precision is developing PBGENE-HBV for the treatment of patients with chronic hepatitis B. Currently
fbak3f4rjt3v5qwwytc99pk41n8toztjz28zybzxovy379kev7r2kggx7s
TGTX
8 Mar 24
SCLEROSIS Relapsing multiple sclerosis (RMS) is a chronic demyelinating disease of the central nervous system (CNS) and includes
m5vxwc03pmvno1 uokzlgfxj9xj
TGTX
1 Mar 24
. ABOUT MULTIPLE SCLEROSIS Relapsing multiple sclerosis (RMS) is a chronic demyelinating disease of the central nervous system (CNS
1wkwmzrma8pjy0eznbljwgdvzhp98 wp4txcz
TGTX
28 Feb 24
at www.briumvipatientsupport.com.ABOUT MULTIPLE SCLEROSIS Relapsing multiple sclerosis (RMS) is a chronic
- Prev
- 1
- Next